z-logo
open-access-imgOpen Access
If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline?
Author(s) -
Christian Haass,
Dennis J. Selkoe
Publication year - 2022
Publication title -
plos biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.127
H-Index - 271
eISSN - 1545-7885
pISSN - 1544-9173
DOI - 10.1371/journal.pbio.3001694
Subject(s) - microglia , amyloid (mycology) , disease , biochemistry of alzheimer's disease , cognitive decline , amyloid β , alzheimer's disease , neuroscience , biology , amyloid precursor protein , clinical trial , dementia , bioinformatics , medicine , pathology , immunology , inflammation

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here